Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Matthew Orloff
PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
Related publications
Brca2Deficiency Sensitizes Cells to PARP Inhibition
Cancer Research
Cancer Research
Oncology
PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Reduced PAK1 Activity Sensitizes FA/BRCA-proficient Breast Cancer Cells to PARP Inhibition
Oncotarget
Oncology
Simultaneous Activation and Inhibition of Autophagy Sensitizes Cancer Cells to Chemotherapy
Oncotarget
Oncology
Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab
International Journal of Cancer
Cancer Research
Oncology
Inhibition of SLC1A5 Sensitizes Colorectal Cancer to Cetuximab
International Journal of Cancer
Cancer Research
Oncology
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
Cancer Research
Cancer Research
Oncology
Genistein Sensitizes Cancer Cells to Chemotherapy: Table 1.
Cancer Research
Cancer Research
Oncology
Tubeimoside-I Sensitizes Colorectal Cancer Cells to Chemotherapy by Inducing ROS-mediated Impaired Autophagolysosomes Accumulation
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology